CoChat

Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias

Open access
Steinacker, Petra, Semler, Elisa, Anderl-Straub, Sarah, Diehl-Schmid, Janine, Schroeter, Matthias L., Uttner, Ingo, Foerstl, Hans, Landwehrmeyer, Bernhard, von Arnim, Christine A.F., Kassubek, Jan, Oeckl, Patrick, Huppertz, Hans-Jürgen, Fassbender, Klaus, Fliessbach, Klaus, Prudlo, Johannes, Roßmeier, Carola, Kornhuber, Johannes, Schneider, Anja, Volk, Alexander E., Lauer, Martin, Danek, Adrian, Ludolph, Albert C., Otto, Markus · 2017 · Neurology
Cited by 89

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Objective: To assess the utility of serum neurofilament for diagnosis and monitoring of primary progressive aphasia (PPA) variants. Methods: We investigated neurofilament light chain (NF-L) levels in blood of 99 patients with PPA (40 with nonfluent variant PPA [nfvPPA], 38 with semantic variant PPA [svPPA], 21 with logopenic variant PPA [lvPPA]) and compared diagnostic performance with that reached by CSF NF-L, phosphorylated neurofilament heavy chain (pNF-H), β-amyloid (Aβ1-42), tau, and phosphorylated tau. The longitudinal change of blood NF-L levels was measured and analyzed for correlation with functional decline and brain atrophy. Results: Serum NF-L is increased in PPA compared to controls and discriminates between nfvPPA/svPPA and lvPPA with 81% sensitivity and 67% specificity (cutoff 31 pg/mL). CSF NF-L, pNF-H, tau, phosphorylated tau, and Aβ1-42 achieved similar performance, and pNF-H was the only marker for discrimination of nfvPPA from svPPA/lvPPA. In most patients with nfvPPA and svPPA, but not lvPPA, serum NF-L increased within follow-up. The increase correlated with functional decline and progression of atrophy of the left frontal lobe of all patients with PPAs and the right middle frontal gyrus of patients with nfvPPA and svPPA. Conclusions: Blood level of NF-L can aid the differential diagnosis of PPA variants, especially in combination with CSF pNF-H. Because serum NF-L correlates with functional decline and atrophy in the disease course, it qualifies as an objective disease status marker. Extended follow-up studies with cases of known neuropathology are imperative. Classification of evidence: This study provides Class I evidence that in patients with PPA, blood levels of NF-L can distinguish the logopenic variant from the nonfluent/agrammatic and semantic variants.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000003688

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 29

  1. 10.1080/02687038.2014.929631 · DOI
  2. 10.1212/WNL.0000000000003154 · DOI · Paper page
  3. 10.1007/s00115-011-3261-3 · DOI
  4. 10.1016/j.cortex.2016.07.004 · DOI
  5. 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  6. 10.1212/WNL.43.11.2412-a · DOI · Paper page
  7. 10.1016/j.neuroimage.2009.10.066 · DOI
  8. 10.1002/mds.26715 · DOI · Paper page
  9. 10.1016/j.neuroimage.2007.09.031 · DOI · Paper page
  10. 10.1176/appi.ajp.162.7.1256 · DOI · Paper page
  11. 10.3174/ajnr.A2514 · DOI
  12. 10.1016/j.mri.2015.12.031 · DOI
  13. 10.1111/ene.12902 · DOI · Paper page
  14. 10.1371/journal.pone.0075091 · DOI · Paper page
  15. 10.1212/WNL.0000000000000261 · DOI · Paper page
  16. 10.1212/WNL.0b013e3182574f79 · DOI · Paper page
  17. 10.1111/jnc.13669 · DOI · Paper page
  18. 10.3233/JAD-141122 · DOI · Paper page
  19. 10.1007/s00415-011-5960-x · DOI
  20. 10.1089/neu.2015.4295 · DOI · Paper page
  21. 10.1002/ana.24552 · DOI · Paper page
  22. 10.1186/alzrt163 · DOI · Paper page
  23. 10.1162/jocn.1996.8.2.135 · DOI · Paper page
  24. 10.1093/brain/awl078 · DOI · Paper page
  25. 10.1212/WNL.0000000000001642 · DOI · Paper page
  26. Steinacker P, Feneberg E, Weishaupt J, et al. Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients. J Neurol Neurosurg Psychiatry 2016;87:12–20.
  27. 10.1038/nrneurol.2009.216 · DOI · Paper page
  28. 10.1007/s00401-011-0839-6 · DOI · Paper page
  29. 10.1212/WNL.0b013e3181ed9c52 · DOI · Paper page

Cited by

See all 89

Metadata

Authors
Steinacker, P., Semler, E., Anderl-Straub, S., Diehl-Schmid, J., Schroeter, M. L., Uttner, I., Foerstl, H., Landwehrmeyer, B., von Arnim, C. A. F., Kassubek, J., Oeckl, P., Huppertz, H.-J., Fassbender, K., Fliessbach, K., Prudlo, J., Roßmeier, C., Kornhuber, J., Schneider, A., Volk, A. E., Lauer, M., Danek, A., Ludolph, A. C., & Otto, M.
Venue
Neurology
Published
2017-03-07
Volume
88
Issue
10
Pages
961-969
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2587397868
Cited by
89
References
9
FWCI
9.17
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias. https://app.cochat.ai/papers/10.1212/wnl.0000000000003688
The paper
Steinacker, P., Semler, E., Anderl-Straub, S., Diehl-Schmid, J., Schroeter, M. L., Uttner, I., Foerstl, H., Landwehrmeyer, B., von Arnim, C. A. F., Kassubek, J., Oeckl, P., Huppertz, H.-J., Fassbender, K., Fliessbach, K., Prudlo, J., Roßmeier, C., Kornhuber, J., Schneider, A., Volk, A. E., . . . Otto, M. (2017). Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias. Neurology. https://doi.org/10.1212/wnl.0000000000003688

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.